Healthcare -
Biotechnology - NASDAQ - US
$ 3.5
-0.293 %
$ 670 M
Market Cap
-8.29
P/E
ABUS - CASH FROM OPERATIONS
Cash from Operations ABUS - Arbutus Biopharma Corporation
-64.8 M
LAST VALUE
-35.43%
2 YEAR CAGR
1.80%
5 YEAR CAGR
-17.97%
10 YEAR CAGR